✦ LIBER ✦

Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults

✍ Scribed by Paolo Palma; Maria Luisa Romiti; Stefania Bernardi; Giuseppe Pontrelli; Nadia Mora; Veronica Santilli; Hyppolite Kuekou Tchidjou; Angela Aquilani; Nicola Cotugno; Federico Alghisi; Vincenzina Lucidi; Paolo Rossi; Iyadh Douagi

Book ID: 113491969
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 375 KB
Volume: 40
Category: Article
ISSN: 1045-1056
DOI: 10.1016/j.biologicals.2011.12.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune response to influenza A (H1N1)v m

Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients

✍ Massimiliano Fabbiani; Simona Di Giambenedetto; Michela Sali; Salvatore Farina; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Immunogenicity, safety and tolerability

Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major

✍ Susanna Esposito; Emanuela D’Angelo; Cristina Daleno; Francesco Peia; Alessia Sc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Immunogenicity and safety of inactivated

Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults

✍ Hana Hakim; Kim J. Allison; Lee-Ann Van De Velde; Yimei Li; Patricia M. Flynn; J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Safety and immunogenicity of an MF59®-ad

Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly

✍ Timo Vesikari; Aino Forstén; Karl-Heinz Herbinger; Giovanni Della Cioppa; Jenny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Immunogenicity and safety of monovalent

Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children

✍ Wanatpreeya Phongsamart; Virat Sirisanthana; Orasri Wittawatmongkol; Alan Malees 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Comparison of the safety, tolerability,

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults

✍ Sharon Frey; Gregory Poland; Sandra Percell; Audino Podda 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 58 KB